Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis

Eric Lawitz; Angie Coste; Fred Poordad; Naim Alkhouri; Nicole Loo; B. Mccolgan; Jacqueline M. Tarrant; Tuan Nguyen; Ling Han; Chuhan Chung; Adrian S. Ray; John G. McHutchison; G. Mani Subramanian; Robert P. Myers; Michael S. Middleton; Claude B. Sirlin; Rohit Loomba; Edna Nyangau; Mark Fitch; Kelvin W. Li; Marc Hellerstein

doi:10.1016/j.cgh.2018.04.042

Related publications

Article2018

Preliminary efficacy and safety of acetyl-CoA carboxylase inhibitor GS-0976 in patients with compensated cirrhosis due to NASH

S. Harrison, Mazen Noureddin, Robert Herring, P. Ruane, B. Mccolgan, Barbara D. Kirby, Christian J. Nelson, Raul Aguilar Schall, C. Jia, Madhu Subramanian, R. Myers, Mark R. Middleton, Claude B. Sirlin, Mark Fitch, K. Li, Marc Hellerstein, Eric Lawitz

Article2018

Su1521 - Preliminary Efficacy and Safety of Acetyl-Coa Carboxylase (ACC) Inhibitor GS-0976 in Patents with Compensated Cirrhosis due to NASH

Stephen A. Harrison, Mazen Noureddin, Robert Herring, Peter Ruane, B. Mccolgan, Macky Natha, Brian J. Kirby, Cara Nelson, Raúl Antonio Aguilar Vera, Catherine Jia, Mani Subramanian, Robert P. Myers, Michael S. Middleton, Claude B. Sirlin, Mark Fitch, Kelvin W. Li, Marc Hellerstein, Eric Lawitz

Article2019

SAT-352-A combination of the ACC inhibitor GS-0976 and the nonsteroidal FXR agonist GS-9674 improves hepatic steatosis, biochemistry, and stiffness in patients with non-alcoholic steatohepatitis

Eric Lawitz, Edward Gane, Peter Ruane, Robert Herring, Ziad Younes, Paul Y. Kwo, Jie Zhang, Catherine Jia, Jay Chuang, B. Mccolgan, Chuhan Chung, Mani Subramanian, Robert P. Myers, Michael S. Middleton, Kelvin W. Li, Marc Hellerstein, Mazen Noureddin, Stephen A. Harrison, Rohit Loomba

Article2019

Human sebum requires de novo lipogenesis, which is increased in acne vulgaris and suppressed by acetyl-CoA carboxylase inhibition

William P. Esler, Gregory J. Tesz, Marc Hellerstein, Carine Beysen, Raja K. Sivamani, Scott Turner, Steven M. Watkins, Paul A. Amor, Santos Carvajal‐Gonzalez, Frank J. Geoly, Kathleen Biddle, Julie J. Purkal, Mark Fitch, Clare Buckeridge, Annette M. Silvia, David A. Griffith, Matthew Gorgoglione, Lauren A. Hassoun, Suzana S. Bosanac, Nicholas B. Vera, Tim Rolph, Jeffrey A. Pfefferkorn,

Article2022

Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients

Eric Lawitz, Kelvin W. Li, Edna Nyangau, Tyler Field, Jen‐Chieh Chuang, Andrew N. Billin, Lulu Wang, Ya Wang, Ryan S. Huss, Chuhan Chung, G. Mani Subramanian, Robert P. Myers, Marc Hellerstein